139 related articles for article (PubMed ID: 30005871)
1. Diosgenin inhibited the expression of TAZ in hepatocellular carcinoma.
Chen Z; Xu J; Wu Y; Lei S; Liu H; Meng Q; Xia Z
Biochem Biophys Res Commun; 2018 Sep; 503(3):1181-1185. PubMed ID: 30005871
[TBL] [Abstract][Full Text] [Related]
2. Rottlerin inhibits cell growth, induces apoptosis and cell cycle arrest, and inhibits cell invasion in human hepatocellular carcinoma.
Shi J; Ning H; He G; Huang Y; Wu Z; Jin L; Jiang X
Mol Med Rep; 2018 Jan; 17(1):459-464. PubMed ID: 29115596
[TBL] [Abstract][Full Text] [Related]
3. Novel diosgenin-amino acid-benzoic acid mustard trihybrids exert antitumor effects via cell cycle arrest and apoptosis.
Wang W; Li C; Chen Z; Zhang J; Ma L; Tian Y; Ma Y; Guo L; Wang X; Ye J; Wang X
J Steroid Biochem Mol Biol; 2022 Feb; 216():106038. PubMed ID: 34861390
[TBL] [Abstract][Full Text] [Related]
4. Diosgenin induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma cells.
Li Y; Wang X; Cheng S; Du J; Deng Z; Zhang Y; Liu Q; Gao J; Cheng B; Ling C
Oncol Rep; 2015 Feb; 33(2):693-8. PubMed ID: 25434486
[TBL] [Abstract][Full Text] [Related]
5. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
[TBL] [Abstract][Full Text] [Related]
6. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells.
Li F; Fernandez PP; Rajendran P; Hui KM; Sethi G
Cancer Lett; 2010 Jun; 292(2):197-207. PubMed ID: 20053498
[TBL] [Abstract][Full Text] [Related]
7. Rottlerin exhibits antitumor activity via down-regulation of TAZ in non-small cell lung cancer.
Zhao Z; Zheng N; Wang L; Hou Y; Zhou X; Wang Z
Oncotarget; 2017 Jan; 8(5):7827-7838. PubMed ID: 27999199
[TBL] [Abstract][Full Text] [Related]
8. Functional and clinical evidence that TAZ is a candidate oncogene in hepatocellular carcinoma.
Guo Y; Pan Q; Zhang J; Xu X; Liu X; Wang Q; Yi R; Xie X; Yao L; Liu W; Shen L
J Cell Biochem; 2015 Nov; 116(11):2465-75. PubMed ID: 25650113
[TBL] [Abstract][Full Text] [Related]
9. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
[TBL] [Abstract][Full Text] [Related]
10. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
[TBL] [Abstract][Full Text] [Related]
11. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma.
Xiao H; Jiang N; Zhou B; Liu Q; Du C
Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
[TBL] [Abstract][Full Text] [Related]
13. Diosgenin increases BBC3 expression in HepG2/C3A cells and alters cell communication in a 3D spheroid model.
da Silva MF; de Lima LVA; Zanetti TA; Felicidade I; Favaron PO; Lepri SR; Lirio Rondina DB; Mantovani MS
Mutat Res Genet Toxicol Environ Mutagen; 2022; 879-880():503512. PubMed ID: 35914860
[TBL] [Abstract][Full Text] [Related]
14. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.
Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258
[TBL] [Abstract][Full Text] [Related]
15. Diosgenin Derivatives as Potential Antitumor Agents: Synthesis, Cytotoxicity, and Mechanism of Action.
Yin H; Zhang MJ; An RF; Zhou J; Liu W; Morris-Natschke SL; Cheng YY; Lee KH; Huang XF
J Nat Prod; 2021 Mar; 84(3):616-629. PubMed ID: 33381964
[TBL] [Abstract][Full Text] [Related]
16. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
Huo S; Yu H; Li C; Zhang J; Liu T
Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
[TBL] [Abstract][Full Text] [Related]
17. 4-Acetylantrocamol LT3, a New Ubiquinone from
Chen YL; Yen IC; Lin KT; Lai FY; Lee SY
Am J Chin Med; 2020; 48(5):1243-1261. PubMed ID: 32668963
[TBL] [Abstract][Full Text] [Related]
18. Diosgenin exhibits tumor suppressive function via down-regulation of EZH2 in pancreatic cancer cells.
Guo W; Chen Y; Gao J; Zhong K; Wei H; Li K; Tang M; Zhao X; Liu X; Nie C; Yuan Z
Cell Cycle; 2019 Aug; 18(15):1745-1758. PubMed ID: 31213123
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and biological studies of diosgenyl analogues.
Huang B; Du D; Zhang R; Wu X; Xing Z; He Y; Huang W
Bioorg Med Chem Lett; 2012 Dec; 22(24):7330-4. PubMed ID: 23153797
[TBL] [Abstract][Full Text] [Related]
20. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
